Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Life Time Group Holdings
LTH
$10.1B
| $6.07M | ﹤0.01% |
248,698
+135,116
| +119% | +$3.04M |
|
1902
Hecla Mining
HL
$11.1B
| $6.07M | ﹤0.01% |
909,811
+691,862
| +317% | +$4.05M |
|
1903
Visteon
VC
$2.79B
| $6.07M | ﹤0.01% |
63,716
+23,893
| +60% | +$2.43M |
|
1904
Rush Enterprises Class A
RUSHA
$6.36B
| $6.06M | ﹤0.01% |
114,759
+78,616
| +218% | +$3.9M |
|
1905
Thomson Reuters
TRI
$43B
| $6.06M | ﹤0.01% |
34,968
-19,218
| -35% | -$3.24M |
|
1906
CALL
J.M. Smucker
SJM
$12.7B
| $6.05M | ﹤0.01% |
50,000
| – | – |
|
1907
Olin
OLN
$2.13B
| $6.04M | ﹤0.01% |
125,913
+34,485
| +38% | +$1.53M |
|
1908
Alight
ALIT
$380M
| $6.04M | ﹤0.01% |
40,792
+24,359
| +148% | +$3.5M |
|
1909
Helmerich & Payne
HP
$3.33B
| $6.04M | ﹤0.01% |
198,415
+151,196
| +320% | +$5.22M |
|
1910
Broadstone Net Lease
BNL
$4.07B
| $6.03M | ﹤0.01% |
318,142
+180,456
| +131% | +$3.19M |
|
1911
National Health Investors
NHI
$3.64B
| $6.03M | ﹤0.01% |
71,703
+54,782
| +324% | +$4.22M |
|
1912
iShares MSCI Japan ETF
EWJ
$22.5B
| $6.03M | ﹤0.01% |
84,247
-683,336
| -89% | -$47.5M |
|
1913
Popular Inc
BPOP
$11.3B
| $6.03M | ﹤0.01% |
60,099
+4,699
| +8% | +$458K |
|
1914
Sweetgreen
SG
$725M
| $6.02M | ﹤0.01% |
169,800
+78,211
| +85% | +$2.37M |
|
1915
CALL
AES
AES
$10.5B
| $6.02M | ﹤0.01% |
+300,000
| New | +$5.31M |
|
1916
Intellia Therapeutics
NTLA
$1.53B
| $6.02M | ﹤0.01% |
292,795
+89,422
| +44% | +$2.06M |
|
1917
NETSCOUT
NTCT
$2.98B
| $6.01M | ﹤0.01% |
276,463
+140,237
| +103% | +$2.76M |
|
1918
Diebold Nixdorf
DBD
$2.65B
| $6.01M | ﹤0.01% |
134,583
-82,101
| -38% | -$3.4M |
|
1919
ABM Industries
ABM
$2.87B
| $6.01M | ﹤0.01% |
113,850
+80,238
| +239% | +$4.24M |
|
1920
Atkore
ATKR
$3.16B
| $5.99M | ﹤0.01% |
70,736
+23,628
| +50% | +$2.57M |
|
|
WBTN
1921
WEBTOON Entertainment Inc
WBTN
$1.26B
| $5.99M | ﹤0.01% |
523,589
+488,779
| +1,404% | +$7.74M |
|
1922
EastGroup Properties
EGP
$10.9B
| $5.99M | ﹤0.01% |
32,060
-2,724
| -8% | -$502K |
|
1923
PUT
Biogen
BIIB
$30.5B
| $5.97M | ﹤0.01% |
+30,800
| New | +$6.44M |
|
|
AIV
1924
Aimco
AIV
$381M
| $5.95M | ﹤0.01% |
658,083
+190,440
| +41% | +$1.69M |
|
1925
Millicom
TIGO
$15.4B
| $5.95M | ﹤0.01% |
219,344
| – | – |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.